Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II

Area of Science:

• Immunology
• Structural Biology
• Microbial Pathogenesis

Background:

• Superantigens like staphylococcal enterotoxin A (SEA) are potent immune activators.
• SEA interacts with major histocompatibility complex (MHC) class II molecules on antigen-presenting cells.
• Understanding SEA's binding mechanism is key to deciphering its immunomodulatory effects.

Purpose of the Study:

• To elucidate the molecular interactions between staphylococcal enterotoxin A (SEA) and human MHC class II molecule HLA-DR1.
• To identify the specific binding sites and residues involved in SEA-HLA-DR1 complex formation.
• To determine the functional significance of these interactions for SEA's activity.

Main Methods:

• Biochemical assays to detect and characterize binding interactions.
• Site-directed mutagenesis to identify key residues in SEA and HLA-DR1.
• Structural analysis to visualize the binding interface.

Main Results:

• SEA binds to HLA-DR1 at two distinct sites: a high-affinity zinc-mediated site on the DR1 beta chain and a low-affinity site on the DR1 alpha chain.
• The zinc-mediated interaction involves specific residues in SEA (H187, H225, D227) and HLA-DR1 beta chain (H81).
• Binding to the beta chain enhances the affinity of a second SEA molecule to the alpha chain via SEA residue F47, enabling one SEA to bind two MHC class II molecules.

Conclusions:

• SEA requires two separate binding sites on MHC class II for optimal T cell activation and antigen-presenting cell stimulation.
• This dual-site binding mechanism, distinct from other staphylococcal enterotoxins like SEB, allows for enhanced cross-linking of MHC class II molecules.
• The findings provide insights into the molecular basis of superantigen activity and potential therapeutic strategies.